Role of anemia in the severity and outcome of chronic heart failure
DOI:
https://doi.org/10.18203/2320-6012.ijrms20261669Keywords:
Anemia, Chronic heart failure, Clinical outcomes, NYHA classificationAbstract
Background: Chronic heart failure is a major cause of morbidity and hospitalization worldwide. Anemia is frequently observed among heart failure patients and may worsen disease severity and clinical outcomes. However, limited data are available regarding this association in Bangladesh. This study aimed to evaluate the role of anemia in the severity and outcome of chronic heart failure.
Methods: This hospital-based observational study was conducted in the department of cardiology at Satkhira Medical College and Hospital from January 2025 to December 2025. A total of 180 patients with chronic heart failure were included. Data on demographic characteristics, anemia status, severity of heart failure according to New York Heart Association (NYHA) classification and clinical outcomes were collected using a structured data sheet.
Results: Among 180 patients with chronic heart failure, 107 (59.4%) had anemia. Most anemic patients had mild anemia (41.1%). Anemic patients were mainly in NYHA class III (43.0%) and IV (19.6%), whereas non-anemic patients were mostly in class II (38.4%) and I (23.3%). Significant differences were found for class I (p<0.001) and class III (p=0.032). Prolonged hospital stay was higher among anemic patients (40.2% vs. 23.3%, p=0.018), and clinical improvement was lower (57.0% versus 75.3%, p=0.012). Readmission and mortality were higher but not statistically significant.
Conclusions: Anemia is common among patients with chronic heart failure and is associated with greater disease severity and poorer clinical outcomes. Early identification and management of anemia may help improve the prognosis of heart failure patients.
References
Pan J, Liu M, Huang J, Chen L, Xu Y. Impact of anemia on clinical outcomes in patients with acute heart failure: a systematic review and meta‐analysis. Clin Cardiol. 2024;47(2):e24228.
Singer CE, Vasile CM, Popescu M, Popescu AI, Marginean IC, Iacob GA, et al. Role of iron deficiency in heart failure- clinical and treatment approach: an overview. Diagnostics. 2023;13(2):304.
Siddiqui SW, Ashok T, Patni N, Fatima M, Lamis A, Anne KK. Anemia and heart failure: a narrative review. Cureus. 2022;14(7).
Graham FJ, Masini G, Pellicori P, Cleland JG, Greenlaw N, Friday J, et al. Natural history and prognostic significance of iron deficiency and anaemia in ambulatory patients with chronic heart failure. Eur J Heart Fail. 2022;24(5):807-17.
Köseoğlu FD, Özlek B. Anemia and iron deficiency predict all-cause mortality in patients with heart failure and preserved ejection fraction: 6-year follow-up study. Diagnostics. 2024;14(2):209.
Packer M, Anker SD, Butler J, Cleland JG, Kalra PR, Mentz RJ, et al. Redefining iron deficiency in patients with chronic heart failure. Circulation. 2024;150(2):151-61.
Alnuwaysir RI, Grote Beverborg N, Hoes MF, Markousis-Mavrogenis G, Gomez KA, van der Wal HH, et al. Additional burden of iron deficiency in heart failure patients beyond the cardio-renal anaemia syndrome: findings from the BIOSTAT-CHF study. Eur J Heart Fail. 2022;24(1):192-204.
Rahamim E, Zwas DR, Keren A, Elbaz-Greener G, Ibrahimli M, Amir O, et al. The ratio of hemoglobin to red cell distribution width: a strong predictor of clinical outcome in patients with heart failure. J Clin Med. 2022;11(3):886.
Filippatos G, Ponikowski P, Farmakis D, Anker SD, Butler J, Fabien V, et al. Association between hemoglobin levels and efficacy of intravenous ferric carboxymaltose in patients with acute heart failure and iron deficiency: an AFFIRM-AHF subgroup analysis. Circulation. 2023;147(22):1640-53.
Manceau H, Ausseil J, Masson D, Feugeas JP, Sablonniere B, Guieu R, et al. Neglected comorbidity of chronic heart failure: iron deficiency. Nutrients. 2022;14(15):3214.
Lindberg F, Lund LH, Benson L, Linde C, Orsini N, Carrero JJ, et al. Iron deficiency in heart failure: Screening, prevalence, incidence and outcome data from the Swedish Heart Failure Registry and the Stockholm CREAtinine Measurements collaborative project. Eur J Heart Fail. 2023;25(8):1270-80.
Rahman JU, Saghir T, Zaman S, Idrees M, Shakil M, Zada S. Frequency of anemia in patients with heart failure admitted to cardiology unit of tertiary care hospital. Indus J Biosci Res. 2025;3(6):466-9.
Sindone A, Doehner W, Manito N, McDonagh T, Cohen-Solal A, Damy T, et al. Practical guidance for diagnosing and treating iron deficiency in patients with heart failure: why, who and how? J Clin Med. 2022;11(11):2976.
Ali MY, Rahman A, Zakia KI, Paul SK, Mim MZ. Clinical epidemiology of cardiovascular disease in advanced chronic kidney disease prior to dialysis to a tertiary care centre in Bangladesh. Bangladesh J Med. 2024;35(2):96-100.
Saeed I, Afridi A, Ahmad SH, Khan A, Khan F, Khan N. Prevalence of anemia in heart failure patients at a tertiary care hospital. Pak Heart J. 2025;58(4):488-94.
Ahmed N, Shaikh K, Kumar A, Bai E, Kour S, Fatima F. Frequency of anemia in patients with heart failure with preserved ejection fraction (HFpEF). Cureus. 2026;18(2).
Savarese G, von Haehling S, Butler J, Cleland JG, Ponikowski P, Anker SD. Iron deficiency and cardiovascular disease. Eur Heart J. 2023;44(1):14-27.
Parsa N, Islam MZ. Assessing the connection between iron deficiency with severity of chronic heart failure. J Invas Clin Cardiol. 2024;6(1):20-4.
Sarate N, Sonawane R, Pai V, Karatela S, Mulkalwar A, Sonawane Sr R, et al. Iron deficiency: a silent threat in patients with heart failure with reduced ejection fraction. Cureus. 2024;16(2).
Sunny M, Islam M, Rahman MA. Relation of clinical hospital outcomes patients with anemia and acute coronary syndrome. Eur J Cardiovasc Med. 2024;14(3).
Graham FJ, Guha K, Cleland JG, Kalra PR. Treating iron deficiency in patients with heart failure: what, why, when, how, where and who. Heart. 2024;110(20):1201-7.
Anker SD, Friede T, Butler J, Talha KM, Placzek M, Diek M, et al. Intravenous ferric carboxymaltose in heart failure with iron deficiency: the FAIR-HF2 DZHK05 randomized clinical trial. Jama. 2025;333(22):1965-76.
Zhang H, Jamieson KL, Grenier J, Nikhanj A, Tang Z, Wang F, et al. Myocardial iron deficiency and mitochondrial dysfunction in advanced heart failure in humans. J Am Heart Assoc. 2022;11(11):e022853.
Downloads
Published
How to Cite
Issue
Section
